| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 16,761,009 | 15,984,992 | 13,577,112 | | Cost of Revenue | 14,478,296 | 13,699,715 | 11,545,719 | | | Gross Profit | 2,282,713 | 2,285,277 | 2,031,393 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 1,607,261 | 1,519,908 | 1,362,149 | | Non Recurring | 1,099,735 | 11,745 | 16,115 | | Others | 69,286 | 66,719 | 46,904 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (493,569) | 686,905 | 606,225 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (10,030) |
-
| (2,605) | | Earnings Before Interest And Taxes | (497,050) | 693,811 | 608,841 | | Interest Expense | 99,863 | 101,628 | 90,564 | | Income Before Tax | (596,913) | 592,183 | 518,277 | | Income Tax Expense | 16,722 | 180,697 | 128,457 | | Minority Interest | (104) | (3,694) | (1,489) | | | | Net Income From Continuing Ops | (613,739) | 407,792 | 388,331 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (613,739) | 407,792 | 388,331 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($613,739) | $407,792 | $388,331 |
|
1.48% Nasdaq 
Income Statement
